Effect of early versus late intervention with inhaled corticosteroids on airway wall thickness in patients with asthma

Respirology

Volumn 13, Issue 7, 2008, Pages 1008-1013

  Kurashima, Kazuyoshi ^a   Kanauchi, Tetsu ^a   Hoshi, Toshiko ^a   Takaku, Yotaro ^a   Ishiguro, Takashi ^a   Takayanagi, Noboru ^a   Ubukata, Mikio ^a   Sugita, Yutaka ^a  

^a Saitama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

Airway remodelling; Asthma; High resolution CT; Inhaled corticosteroid

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID DERIVATIVE; THEOPHYLLINE DERIVATIVE;

ADULT; ARTICLE; ASTHMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EARLY INTERVENTION; FORCED EXPIRATORY VOLUME; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LUNG; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 54349108136     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01384.x     Document Type: Article

References (35)

1. Barnes PJ. The role of inflammation and anti-inflammatory medication in asthma. Respir. Med. 2002 96 (Suppl. A S9 15.
2. Global Initiative for Asthma. NHLBI/WHO Workshop Report. NIH Publication No. 02-3659. National Heart, Lung and Blood Institute, Bethesda, April 2002.
3. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Eng. J. Med. 1994 331 : 700 5.
4. Selroos O, Pietinalho A, Löfroos AB, Riska H. Effect of early versus late intervention with inhaled corticosteroids in asthma. Chest 1995 108 : 1228 34.
5. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 1993 147 : 405 10.
6. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D-morphometric study. Am. Rev. Respir. Dis. 1993 148 : 720 6.
7. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP et al. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 1990 142 : 434 57.
8. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N et al. Eosinophilic inflammation in asthma. N. Engl. J. Med. 1990 323 : 1033 9.
9. Awadh N, Muller NL, Park CS, Abbound RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed scanning. Thorax 1998 53 : 248 53.
10. Boulet L, Bélanger M, Carrier G. Airway responsiveness and bronchial-wall thickness in asthma with or without fix airflow obstruction. Am. J. Respir. Crit. Care Med. 1995 152 : 865 71.
11. King GG, Müller NL, Paré PD. Evaluation of airways in obstructive pulmonary disease using high-resolution computed tomography. Am. J. Respir. Crit. Care Med. 1999 159 : 992 1004.
12. Harmanci E, Kebapci M, Metintas M, Ozakan R. High-resolution computed tomography findings are correlated with disease severity in asthma. Respiration 2002 69 : 420 6.
13. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K et al. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am. J. Respir. Crit. Care Med. 2003 168 : 983 8.
14. Lynch DA, Newell J, Hale V, Dyer D, Corkery K et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. Am. J. Roentgenol. 1999 173 : 53 8.
15. Expert Panel for Asthma Prevention and Management Guidelines. Immunological and Allergic Diseases Research Projects, Japanese Ministry of Welfare, Epidemiology. In : Makino S, Furusho M, Miyamoto T (eds) Asthma Prevention and Management Guidelines, Kyowa Kikaku Tsushin, Tokyo, 2003.
16. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM et al. Computed tomography of the lungs in asthma; influence of disease severity and etiology. Am. J. Respir. Crit. Care Med. 1996 153 : 110 14.
17. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000 161 : 1720 45.
18. Lee YM, Park JS, Hwang JH, Park SW, Uh ST et al. High-resolution CT findings in patients with near-fatal asthma. Chest 2004 126 : 1840 8.
19. Niimi A, Matsumoto H, Amitani R, Nakano Y, Sakai H et al. Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am. J. Med. 2004 116 : 725 31.
20. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984 34 : 131 6.
21. Kips JC, Pauwels RA. Airway wall remodeling: does it occur and what does it mean? Clin. Exp. Allergy 1999 29 : 1457 66.
22. Laitinen LA, Laitinen A, Haahtela TA. Comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group control trial. J. Allergy Clin. Immunol. 1992 90 : 32 42.
23. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I et al. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 1997 156 : 951 8.
24. Olivieri D, Chetta A, Del-Donno M, Bertorelli G, Casalini A et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am. J. Respir. Crit. Care Med. 1997 155 : 1864 71.
25. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 1994 150 : 17 22.
26. Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloprotease-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 1999 104 : 356 63.
27. Chetta A, Zanini A, Foresi A, Del-Donno M, Castagnaro A et al. Vascular component of airway remodeling in asthma is reduced by high dose of flucicasone. Am. J. Respir. Crit. Care Med. 2003 167 : 751 7.
28. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur. Respir. J. 1988 1 : 883 9.
29. Vanacker NJ, Palmans E, Pauwels RA, Kips JC. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am. J. Respir. Crit. Care Med. 2001 163 : 674 9.
30. Niimi A, Matsumoto H, Amitani R, Nakano Y, Mishima M et al. Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. Am. J. Respir. Crit. Care Med. 2000 162 : 1518 23.
31. Little SA, Sproule MW, Cowan MD, MacLeod KJ, Robertoson M et al. High resolution computed tomographic assessement of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax 2002 57 : 247 53.
32. Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002 57 : 242 6.
33. Gono H, Fujimoto K, Kawakami S, Kubo K. Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma. Eur. Respir. J. 2003 22 : 965 71.
34. Paganin F, Trussard V, Seneterre E, Chanez P, Giron J et al. Chest radiography and high resolution computed tomography of the lungs in asthma. Am. Rev. Respir. Dis. 1992 146 : 1084 7.
35. Qiu Z, Fujimura M, Kurashima K, Nakao S, Mukaida N. Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6-deficient mice following chronic exposure to aerosolized antigen. Clin. Exp. Allergy. 2004 34 : 1321 8.